Bing Wei

Bing Wei

Auto-generated profile, based on publicly available information

Bing Wei

Department of Pediatrics, No.2 Hospital of China Medical University, Shenyang 110004, China

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2011 in Journal of Inflammation
Verified
Journal Article
Open access
PDF file
MLMiao Li
Miao Li
YSYun-Xiao Shang
Yun-Xiao Shang
BWBing Wei
Bing Wei
YYYungang Yang
Yungang Yang
Airway remodeling and airway hyper-responsiveness are prominent features of asthma. Neurogenic inflammation participates in the development of asthma. Neurokinin substance P acts by binding to neurokinin-1 receptor (NK-1R). Airway smooth muscle cells (ASMC) are important effector cells in asthma. Increases in ASMC proliferation, migration, and cytoplasmic Ca2+ concentration are critical to airway remodeling and hyper-responsiveness. The effects of substance P on ASMC were investigated in Wistar rats challenged with a previously described asthmatic rat model. To exclude possible influences from other factors, the role of substance P was also investigated in primary cultured rat ASMC. Substance P and WIN62577-induced changes in cytoplasmic Ca2+ concentration were observed by fluorescence microscopy, and expression of Ca2+ homeostasis-regulating genes was assessed with real-time PCR. We found that cytoplasmic Ca2+ concentration increased in normal rat ASMC treated with substance P, but decreased in asthmatic rat ASMC treated with WIN62577, an antagonist of NK-1R. Real-time PCR analysis revealed increased Serca2 mRNA expression but decreased Ip3r mRNA expression after WIN62577 treatment in asthmatic rat ASMC. Flow cytometric analysis (FCM) revealed that most asthmatic rat ASMC stayed at G1 phase after combined treatment with WIN62577 and IL-13 in vitro. Transwell analysis suggested that ASMC migration was reduced after WIN62577 treatment. Therefore, we conclude that NK-1R is related to asthma mechanisms and a NK-1R antagonist downregulates calcium concentration in asthmatic ASMC by increasing Serca2 mRNA and decreasing Ip3r mRNA expression. The NK-1R antagonist WIN62577 inhibited ASMC IL-13-induced proliferation and ASMC migration in vitro and therefore may be a new therapeutic option in asthma.


1 November 2015
Verified
Journal Article
Closed access
BWBing Wei
Bing Wei
YLYa-Li Liu
Ya-Li Liu
CZChao Zhang
Chao Zhang
YSYun-Xiao Shang
Yun-Xiao Shang
HZHan Zhang
Han Zhang
MLMiao Li
Miao Li

Verified
Journal Article
Closed access
JJJing-Jing Jia
Jing-Jing Jia
BWBing Wei
Bing Wei
LLLing-Xue Li
Ling-Xue Li
MRMeng-Yang Ren
Meng-Yang Ren
SZShi-Nan Zhang
Shi-Nan Zhang
YZYu-Xuan Zhang
Yu-Xuan Zhang